CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $596,517 | +12.1% | 51,028 | +28.9% | 0.00% | – |
| Q2 2023 | $532,143 | -17.2% | 39,594 | +2.1% | 0.00% | – |
| Q1 2023 | $642,823 | -7.1% | 38,771 | +4.2% | 0.00% | – |
| Q4 2022 | $692,199 | +41.6% | 37,215 | -2.4% | 0.00% | – |
| Q3 2022 | $488,977 | +79.2% | 38,112 | -2.1% | 0.00% | – |
| Q2 2022 | $272,899 | -18.0% | 38,930 | -3.0% | 0.00% | – |
| Q1 2022 | $332,785 | -4.6% | 40,143 | -22.1% | 0.00% | – |
| Q4 2021 | $349,000 | +21.6% | 51,530 | -4.9% | 0.00% | – |
| Q3 2021 | $287,000 | -14.1% | 54,175 | -6.8% | 0.00% | – |
| Q2 2021 | $334,000 | +17.6% | 58,143 | -5.6% | 0.00% | – |
| Q1 2021 | $284,000 | +40.6% | 61,610 | +2.0% | 0.00% | – |
| Q4 2020 | $202,000 | +14.8% | 60,392 | +2.0% | 0.00% | – |
| Q3 2020 | $176,000 | -34.8% | 59,227 | 0.0% | 0.00% | – |
| Q2 2020 | $270,000 | +12.0% | 59,227 | -5.2% | 0.00% | – |
| Q1 2020 | $241,000 | +10.0% | 62,505 | +6.8% | 0.00% | – |
| Q4 2019 | $219,000 | -32.2% | 58,518 | -4.6% | 0.00% | – |
| Q3 2019 | $323,000 | +32.9% | 61,335 | -3.0% | 0.00% | – |
| Q2 2019 | $243,000 | -28.9% | 63,211 | -5.8% | 0.00% | – |
| Q1 2019 | $342,000 | +180.3% | 67,107 | +5.8% | 0.00% | – |
| Q4 2018 | $122,000 | -52.7% | 63,405 | -7.1% | 0.00% | – |
| Q3 2018 | $258,000 | +6.6% | 68,237 | -12.1% | 0.00% | – |
| Q2 2018 | $242,000 | +49.4% | 77,635 | +14.1% | 0.00% | – |
| Q1 2018 | $162,000 | -26.7% | 68,058 | +20.4% | 0.00% | – |
| Q4 2017 | $221,000 | +44.4% | 56,542 | -6.8% | 0.00% | – |
| Q3 2017 | $153,000 | -12.6% | 60,682 | -3.9% | 0.00% | – |
| Q2 2017 | $175,000 | +2816.7% | 63,114 | +1861.3% | 0.00% | – |
| Q1 2017 | $6,000 | +100.0% | 3,218 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | -25.0% | 3,218 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | +100.0% | 3,218 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | -96.7% | 3,218 | -94.1% | 0.00% | – |
| Q1 2016 | $60,000 | -50.4% | 54,176 | +9.3% | 0.00% | – |
| Q4 2015 | $121,000 | -18.2% | 49,577 | 0.0% | 0.00% | – |
| Q3 2015 | $148,000 | -27.8% | 49,577 | 0.0% | 0.00% | – |
| Q2 2015 | $205,000 | +10150.0% | 49,577 | +8149.1% | 0.00% | – |
| Q3 2014 | $2,000 | 0.0% | 601 | 0.0% | 0.00% | – |
| Q2 2014 | $2,000 | +100.0% | 601 | 0.0% | 0.00% | – |
| Q1 2014 | $1,000 | – | 601 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |